The hormone glucose-dependent insulinotropic polypeptide (GIP) is considered obesogenic. In contrast, GIP receptor agonists (GIPRAs) have shown reduced feeding and body weight in an obese mouse model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback